Tolerability of the synthetic retinoid fenretinide® (HPR)
- 1 May 1989
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 25 (5), 805-808
- https://doi.org/10.1016/0277-5379(89)90124-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral IsotretinoinNew England Journal of Medicine, 1988
- MENSTRUAL CHANGES IN A PATIENT TREATED WITH ETRETINATEThe Lancet, 1987
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- Observations of vitamin A toxicity in three patients with renal failure receiving parenteral alimentationThe American Journal of Clinical Nutrition, 1986
- Abnormal Retinal Function Associated With Fenretinide, a Synthetic RetinoidAmerican Journal of Ophthalmology, 1986
- Adverse Ocular Reactions Possibly Associated With IsotretinoinAmerican Journal of Ophthalmology, 1985
- Chemoprevention of cervix cancer: Phase I–II: A feasibility study involving the topical vaginal administration of retinyl acetate gelGynecologic Oncology, 1985
- Phase I trial of retinol in cancer patients.Journal of Clinical Oncology, 1983
- Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin ACancer, 1980
- Stimulation of Immune Response in Lung Cancer Patients by Vitamin A TherapyOncology, 1977